Evidence map›Paper›PMID 38615147›Full record

ArticleScientific reports2024

Probing the expression and adhesion of glycans involved in Helicobacter pylori infection.

Daniel Sijmons, Simon Collett, Caroline Soliman, Andrew J Guy, Andrew M Scott, Lindy G Durrant, Aaron Elbourne, Anna K Walduck, Paul A Ramsland

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A Prognostic Riskscore Model Related toInternational journal of genomics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Daniel SijmonsSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia.
Simon CollettSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia.
Caroline SolimanSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia.
Andrew J GuySchool of Science, RMIT University, Melbourne, VIC, 3000, Australia.
Andrew M ScottOlivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.
Lindy G DurrantScancell Limited, University of Nottingham Biodiscovery Institute, Nottingham, UK.
Aaron ElbourneSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia.
Anna K WalduckSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia. anwalduck@csu.edu.au.
Paul A RamslandSchool of Science, RMIT University, Melbourne, VIC, 3000, Australia. paul.ramsland@rmit.edu.au.
RMIT University · AUAustin Health · AUSociety of Hospital Pharmacists of Australia · AUUniversity of Melbourne · AUUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori infects approximately half the human population and has an unusual infective niche of the human stomach. Helicobacter pylori is a major cause of gastritis and has been classified as a group 1 carcinogen by the WHO. Treatment involves triple or quadruple antibiotic therapy, but antibiotic resistance is becoming increasingly prevalent. Helicobacter pylori expresses certain blood group related antigens (Lewis system) as a part of its lipopolysaccharide (LPS), which is thought to assist in immune evasion. Additionally, H. pylori LPS participates in adhesion to host cells alongside several adhesion proteins. This study profiled the carbohydrates of H. pylori reference strains (SS1 and 26695) using monoclonal antibodies (mAbs) and lectins, identifying interactions between two carbohydrate-targeting mAbs and multiple lectins. Atomic force microscopy (AFM) scans were used to probe lectin and antibody interactions with the bacterial surfaces. The selected mAb and lectins displayed an increased adhesive force over the surface of the curved H. pylori rods. Furthermore, this study demonstrates the ability of anti-carbohydrate antibodies to reduce the adhesion of H. pylori 26695 to human gastric adenocarcinoma cells via AFM. Targeting bacterial carbohydrates to disrupt crucial adhesion and immune evasion mechanisms represents a promising strategy for combating H. pylori infection.

Indexed as

Blood Group AntigensHelicobacter InfectionsHelicobacter pyloriAntibodies, MonoclonalHumansLectinsLipopolysaccharidesPolysaccharidesAntibodies, MonoclonalBlood Group AntigensLectinsLipopolysaccharidesPolysaccharides

Identifiers

PMID38615147
PMCPMC11016089
OpenAlexW4394785664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.